Cost-Utility Analysis of STN1013001, a Latanoprost Cationic Emulsion, versus Other Latanoprost Formulations (Latanoprost) in Open-Angle Glaucoma or Ocular Hypertension and Ocular Surface Disease in France

Lazzaro C., Van Steen C., Aptel F., Schweitzer C., Angelillo L.

2022
Journal of Ophthalmology

Therapeutic Area

Glaucoma

Affiliations

Studio di Economia Sanitaria, Milan, Italy; Santen GmbH, München, Germany; Department of Ophthalmology, University Hospital, CHU Grenoble-Alpes, Grenoble, France; CHU Bordeaux, Department of Ophthalmology, University of Bordeaux, Bordeaux, 33000, France; Inserm, Bordeaux Population Health Research Center, Team LEHA, UMR 1219, Bordeaux, 33000, France

Related Publications

An Exploratory Study of Machine Learning-Based Open-Angle Glaucoma Detection Using Specific Autoantibodies

Takada N., Ishikawa M., Ninomiya T., Izumi Y., Sato K., Kunikata H., Yokoyama Y., Tsuda S., Fukuda E., Yamaguchi K., Ono C., Kirihara T., Shintani C., Hanyuda A., Goshima N., Zorumski C.F., NakazawaT.

Relaxation of Precontracted Ciliary Artery and Ciliary Muscle In Vitro by Kinin Peptides: Relevance to Retinal Blood Flow and Intraocular Pressure Regulation

Sharif N.A., Kulkarni-Chitnis M., Okolie A., Chaudhry S.D., Njie-Mbye Y.F., Ohia S.E.

The Role of EP3 Agonism in Intraocular Pressure-Lowering by Sepetaprost, a Novel Dual Agonist of FP and EP3 Receptors, in Monkeys

Maki K., Kimura E., Yamamoto Y., Fuwa M., Toris C.B., Fan S., Shimazaki A., Kato M.

View all Glaucoma publications